Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 1.00 |
| ▸ | IDO1 | P14902 | 3/20 | 1.00 |
| ▸ | MAPK10 | P53779 | 2/20 | 1.00 |
| ▸ | GAA | P10253 | 2/20 | 1.00 |
| ▸ | TTK | P33981 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | ALPL | P05186 | 1/20 | 1.00 |
| ▸ | NPC1 | O15118 | 1/20 | 0.75 |
| ▸ | TP53 | P04637 | 1/20 | 0.75 |
| ▸ | RAB9A | P51151 | 1/20 | 0.75 |
| ▸ | MAP2K4 | P45985 | 3/20 | 0.68 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.67 |
| ▸ | AURKA | O14965 | 1/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | MAPKAPK3 | Q16644 | 1/20 | 0.62 |
| ▸ | MAPK6 | Q16659 | 1/20 | 0.62 |
| ▸ | DCLK1 | O15075 | 1/20 | 0.61 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.61 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30768403 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KDM4EIDO1MAPK10GAA | |
| SCHEMBL17178615 | 0.96 | ALDH1A1 (0.92) | ALDH1A1KDM4EIDO1MAPK10GAA | |
| SCHEMBL27968462 | 0.92 | ALDH1A1 (0.85) | ALDH1A1KDM4EIDO1MAPK10GAA | |
| SCHEMBL1672674 | 0.88 | IDO1 (0.78) | ALDH1A1KDM4EIDO1MAPK10GAA | |
| SCHEMBL18977088 | 0.86 | TTK (0.75) | ALDH1A1KDM4EIDO1MAPK10GAA | |
| SCHEMBL10533662 | 0.85 | IDO1 (0.74) | ALDH1A1KDM4EIDO1MAPK10GAA | |
| SCHEMBL19597646 | 0.85 | TTK (0.72) | ALDH1A1KDM4EIDO1MAPK10GAA | |
| Propionic Acid SCHEMBL4552403 | 0.84 | KDM4E (0.71) | ALDH1A1KDM4EIDO1MAPK10GAA | |
| SCHEMBL5377572 | 0.84 | ALDH1A1 (0.71) | ALDH1A1KDM4EIDO1MAPK10GAA | |
| SCHEMBL4480025 | 0.84 | ALDH1A1 (0.71) | ALDH1A1KDM4EIDO1MAPK10GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 283 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190081244-A1 | Space-Through Charge Transfer Compound, and Organic Light Emitting Diode and Display Device Using the Same | LG DISPLAY CO., LTD. (KR) | 2019-03-14 | — | — | US | claimed |
| US-10141515-B2 | Space-through charge transfer compound, and organic light emitting diode and display device using the same | LG DISPLAY CO., LTD. (KR) | 2018-11-27 | — | — | US | claimed |
| CN-105601613-B | Space charge transfer compounds and the Organic Light Emitting Diode and display device for using the compound | 乐金显示有限公司 | 2018-08-07 | — | — | CN | claimed |
| EP-3010064-B1 | SPACE-THROUGH CHARGE TRANSFER COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME | LG DISPLAY CO LTD (KR) | 2017-07-19 | — | — | EP | claimed |
| CN-105601613-A | Space-through charge transfer compound, organic light emitting diode device and display device using the same | LG DISPLAY CO LTD | 2016-05-25 | — | — | CN | claimed |
| US-20160111650-A1 | SPACE-THROUGH CHARGE TRANSFER COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME | LG DISPLAY CO., LTD. (KR) | 2016-04-21 | — | — | US | claimed |
| EP-3010064-A1 | SPACE-THROUGH CHARGE TRANSFER COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME | LG Display Co., Ltd. (KR) | 2016-04-20 | — | — | EP | claimed |
| EP-2164329-A2 | TISSUE NON-SPECIFIC ALKALINE PHOSPHATASE INHIBITORS AND USES THEREOF FOR TREATING VASCULAR CALCIFICATION | The Burnham Institute for Medical Research (US) | 2010-03-24 | — | — | EP | claimed |
| US-20090156560-A1 | TISSUE NON-SPECIFIC ALKALINE PHOSPHATASE INHIBITORS AND USES THEREOF FOR TREATING VASCULAR CALCIFICATION | SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE | 2009-06-18 | — | — | US | claimed |
| WO-2009017863-A2 | TISSUE NON-SPECIFIC ALKALINE PHOSPHATASE INHIBITORS AND USES THEREOF FOR TREATING VASCULAR CALCIFICATION | BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) | 2009-02-05 | — | — | WO | claimed |
| US-4925901-A | STORAGE STAABILITY, ONIUM ION CATALYST | THE DOW CHEMICAL COMPANY (US) | 1990-05-15 | — | — | US | claimed |
| CN-120192312-A | Organic compound, organic electroluminescent device and electronic device comprising the same | 陕西莱特光电材料股份有限公司 | 2025-06-24 | — | — | CN | disclosed |
| US-11878977-B2 | JAK inhibitors containing a 4-membered heterocyclic amide | THERAVANCE BIOPHARMA R&D IP, LLC (US) | 2024-01-23 | — | — | US | disclosed |
| CN-117177591-A | Preparation method of aromatic hydrocarbon benzodiazole one-dimensional structure-perovskite composite film and solar cell | 西北工业大学 | 2023-12-05 | — | — | CN | disclosed |
| US-20230382926-A1 | COMPOUNDS AND USES THEREOF | THE UNIVERSITY OF THE WEST INDIES (TT) | 2023-11-30 | — | — | US | disclosed |
| EP-0172427-A2 | Process for production of vinyl chloride polymer | Shin-Etsu Chemical Co., Ltd. (JP) | 1986-02-26 | — | — | EP | disclosed |
| EP-0162216-A1 | 2,4,5-Triphenyl-1,2,3-triazoles and thier use | BASF Aktiengesellschaft (DE) | 1985-11-27 | — | — | EP | disclosed |
| EP-0150419-A1 | 2H-v-triazolyl[4,5-b]pyridines and their use | BASF Aktiengesellschaft (DE) | 1985-08-07 | — | — | EP | disclosed |
| US-3994890-A | TRANQUILIZERS, ANTIDEPRESSANTS, ANTIINFLAMMATORY | CHUGAI SEIYAKU KABUSHIKI KAISHA (JA) | 1976-11-30 | — | — | US | disclosed |
| US-3994890-A | TRANQUILIZERS, ANTIDEPRESSANTS, ANTIINFLAMMATORY | CHUGAI SEIYAKU KABUSHIKI KAISHA (JA) | 1976-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230382926-A1 | COMPOUNDS AND USES THEREOF | CFTR, CCL11, CEL | ALDH1A1 1002/4885KDM4E 4211/4885IDO1 1547/4885 |
| US-10141515-B2 | Space-through charge transfer compound, and organic light emitting diode and display device using the same | NLRP1, NLRP3, CYBA | ALDH1A1 1089/4885KDM4E 2885/4885IDO1 1748/4885 |
| US-11878977-B2 | JAK inhibitors containing a 4-membered heterocyclic amide | JAK1, JAK2, JAK3 | ALDH1A1 1814/4885KDM4E 282/4885IDO1 526/4885 |
| US-20090156560-A1 | TISSUE NON-SPECIFIC ALKALINE PHOSPHATASE INHIBITORS AND USES THEREOF FOR TREATING VASCULAR CALCIFICATION | ALPL, CNDP2, ALPI | ALDH1A1 1571/4885KDM4E 1913/4885IDO1 2242/4885 |
| US-20160111650-A1 | SPACE-THROUGH CHARGE TRANSFER COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME | NLRP1, NLRP3, CYBA | ALDH1A1 1089/4885KDM4E 2885/4885IDO1 1748/4885 |
| US-20190081244-A1 | Space-Through Charge Transfer Compound, and Organic Light Emitting Diode and Display Device Using the Same | NLRP1, NLRP3, CYBA | ALDH1A1 1089/4885KDM4E 2885/4885IDO1 1748/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.